Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Hideo Morimoto

Study Design and Baseline Characteristics of the EXPAND Study: Evaluation of Effectiveness and Safety of Xa Inhibitor, Rivaroxaban for the Prevention of Stroke and Systemic Embolism in a Nationwide Cohort of Japanese Patients Diagnosed as Non-Valvular Atrial Fibrillation

Tohoku Journal of Experimental Medicine

English

Related publications

Primary and Secondary Prevention of Stroke and Systemic Embolism With Rivaroxaban in Patients With Non-Valvular Atrial Fibrillation

Heart and Vessels

Cardiovascular Medicine

Cardiology

2018

English

Cost-Effectiveness of Rivaroxaban for the Prevention of Stroke in Patients With Non-Valvular Atrial Fibrillation – A Multinational Study

English

Ds2 - Effectiveness and Safety of Standard and Reduced Doses of Dabigatran Versus Rivaroxaban in Non-Valvular Atrial Fibrillation: A Cohort Study in the SNDS French Nationwide Claims Database

English

Pcv42 - A Pharmacoeconomic Analysis of the Use of Apixaban for the Prevention of Stroke and Systemic Embolism in Russian Patients With Non-Valvular Atrial Fibrillation

English

Cost-Effectiveness of Apixaban for Stroke Prevention in Non-Valvular Atrial Fibrillation in Saudi Arabia

Annals of Saudi Medicine

Medicine

2019

English

Adherence to Medication and Characteristics of Japanese Patients With Non-Valvular Atrial Fibrillation

Journal of Cardiology

Cardiovascular Medicine

Cardiology

2017

English

Comparative Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants and Warfarin in Patients With Atrial Fibrillation: Propensity Weighted Nationwide Cohort Study

British Medical Journal

Medicine

2016

English

Pcv84 - Cost-Effectiveness Analysis of Apixaban Versus Edoxaban for Stroke Prevention in Non-Valvular Atrial Fibrillation Spanish Patients

English

PCV7 a Mixed Treatment Comparison (MTC) to Compare the Efficacy of Anti-Thrombotic Agents in the Prevention of Stroke and Systemic Embolism (SE) in Patients With Non-Valvular Atrial Fibrillation (NVAF)

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Hideo Morimoto

Study Design and Baseline Characteristics of the EXPAND Study: Evaluation of Effectiveness and Safety of Xa Inhibitor, Rivaroxaban for the Prevention of Stroke and Systemic Embolism in a Nationwide Cohort of Japanese Patients Diagnosed as Non-Valvular Atrial Fibrillation

Related publications

Primary and Secondary Prevention of Stroke and Systemic Embolism With Rivaroxaban in Patients With Non-Valvular Atrial Fibrillation

Cost-Effectiveness of Rivaroxaban for the Prevention of Stroke in Patients With Non-Valvular Atrial Fibrillation – A Multinational Study

Ds2 - Effectiveness and Safety of Standard and Reduced Doses of Dabigatran Versus Rivaroxaban in Non-Valvular Atrial Fibrillation: A Cohort Study in the SNDS French Nationwide Claims Database

Pcv42 - A Pharmacoeconomic Analysis of the Use of Apixaban for the Prevention of Stroke and Systemic Embolism in Russian Patients With Non-Valvular Atrial Fibrillation

Cost-Effectiveness of Apixaban for Stroke Prevention in Non-Valvular Atrial Fibrillation in Saudi Arabia

Adherence to Medication and Characteristics of Japanese Patients With Non-Valvular Atrial Fibrillation

Comparative Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants and Warfarin in Patients With Atrial Fibrillation: Propensity Weighted Nationwide Cohort Study

Pcv84 - Cost-Effectiveness Analysis of Apixaban Versus Edoxaban for Stroke Prevention in Non-Valvular Atrial Fibrillation Spanish Patients

PCV7 a Mixed Treatment Comparison (MTC) to Compare the Efficacy of Anti-Thrombotic Agents in the Prevention of Stroke and Systemic Embolism (SE) in Patients With Non-Valvular Atrial Fibrillation (NVAF)